Medicine Information

Marketing Authorisation - Medicinal Products


Marketing Authorisation: Medicinal Products The case of R (on the application of Merck Sharp and Dohme Ltd) v Licensing Authority [2005], concerned the application for marketing authorisation for a generic product which was based on Product C (see below).

The claimant had marketing authorisations for three medicinal products used in the treatment of osteoporosis and three generic companies sought marketing authorisation for Product C.

Product A - was authorised by the European Community in 1993;

Product B - was authorised in 2000

Product C - was a generic product based on Product B (a copy of Product B).

When a company applies for marketing authorisation for a product, it is a requirement under the European Parliament and Council Directive (EC) 2001/83 (the "Directive"), to supply a full set of data in order to show the safety and efficacy of the product.

There are instances under the Directive when an applicant can simply rely on data submitted in respect of a previously authorised product. For instance, the applicant could refer to data already submitted in respect of a product with marketing authorisation, where the applicant is seeking authorisation for a product 'essentially similar' to a product holding a marketing authorisation for ten years (as per the United Kingdom and pursuant to art 10(i)(a)(iii) of the Directive).

In seeking marketing authorisation for Product C, the generic companies relied on data submitted in relation to Product A and Product B. However, although Product A and Product B contained the same active ingredient, they were not 'essentially similar' within the meaning of the Directive. This meant that they differed in respect of their posology (the schedule of dosage). The defendant accepted that the generic companies did not have to provide any further data but the claimant argued that such an approach was unlawful and in breach of the Directive. The claimant made a reference to the European Court of Justice ("Court of Justice").

The claimant contended that the issue was as yet unresolved by the rules laid down in previous decisions of the ECJ. In particular, it was argued, that there had been no cases where a difference in posology had been the subject of a decision.

The application was dismissed. The ECJ held that:

The principles laid down by the ECJ in earlier decisions were clearly applicable in this case and there was no uncertainty;

Although it was true that a change in posology had not previously been the subject of a decision, it was for the ECJ to interpret the EC Treaty and the relevant principles by which it was to be interpreted, and for the domestic court to apply those principles to the particular case. No new principles arose in the instant case.

If you require further information contact us.

Email: enquiries@rtcoopers.com

RT COOPERS, 2005. This Briefing Note does not provide a comprehensive or complete statement of the law relating to the issues discussed nor does it constitute legal advice. It is intended only to highlight general issues. Specialist legal advice should always be sought in relation to particular circumstances.

Rosanna Cooper is a partner in RT Coopers Solicitors a full service law firm in London. The firm specialises in patents, trade marks, copyright, designs, technology transfer, biotechnology and pharmaceutical law. The firm has a flexible approach to fees and provides the highest quality legal advice.

Contact us at enquiries@rtcoopers.com. visit our website at http://www.rtcoopers.com


MORE RESOURCES:
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news


Inside Higher Ed

'To See the Suffering'
Inside Higher Ed
Being selected to give the Jefferson Lecture is considered the highest honor the federal government bestows in the humanities, and this year that honor went to Rita Charon, a pioneer in the field of narrative medicine. Charon, a Harvard University ...



Washington Post

Drugmakers may have to disclose prices of medicine in television ads
Washington Post
The nation's top health official proposed on Monday that pharmaceutical companies be required to include the list price of medicines in television advertisements to consumers — the boldest in a series of efforts by the Trump administration to curb ...
Drugmakers may have to disclose prices of medicine in TV adsThe Mercury News
US says medicine ads should include list pricesPMLiVE
Health chief wants medicine ads on TV to include list pricesArkansas Democrat-Gazette (blog)
HHS.gov -PhRMA
all 331 news articles »


Forbes

Pharma Failures Actually Advance Medicine
Forbes
Creating new medicines is extremely difficult and only one in 10 experimental medicines that enter human trials actually results in an FDA approval. Lowe acknowledges these challenges. But he also refers to these failures as “drug development sins” – a ...



UCLA Newsroom

UCLA neurosurgeon named to National Academy of Medicine
UCLA Newsroom
Dr. Linda Liau, an internationally renowned neurosurgeon-scientist and chair of the neurosurgery department at the David Geffen School of Medicine at UCLA, has been elected by her peers to the National Academy of Medicine, one of the highest honors in ...
Interoperability remains limited, according to the National Academy of MedicineHealthcare Finance News
Dell Medical School Professor Joins Prestigious National Academy of MedicineUT News | The University of Texas at Austin
Duke professor elected to National Academy of MedicineDuke Chronicle
UCSF News Services -The Hub at Johns Hopkins -Wichita Eagle
all 42 news articles »


McCann Health's Global Scientific Council brings a valuable new resource for medicine, clients
Medical Marketing and Media
This Council is designed to help patients, healthcare practitioners and society as a whole better understand the complexities surrounding health and medicine. Together, McCann Health's 450-plus strong community of PhDs, MDs, pharmacists and other ...



WJHL-TV News Channel 11

ETSU Family Medicine presented HIMSS Davies Award of Excellence
WJHL-TV News Channel 11
JOHNSON CITY, Tenn. - A successful initiative by the Department of Family Medicine at East Tennessee State University to improve collaboration and communication after patients are discharged from the hospital was recognized by the Healthcare ...



ScienceNordic

An enlightened approach to “illegal” drugs will revolutionise medicine and science
ScienceNordic
Cannabis was considered a medicine for millennia, when in the 1930s, following pressure from the USA, it was decided that it should be removed from medicine in a vain attempt to limit recreational use. In the ensuing 80 years, the number of people ...



Harvard Medical School

6 HMS Faculty Elected to National Academy of Medicine
Harvard Medical School
Six HMS faculty members are among 75 researchers and clinicians elected as regular members of the National Academy of Medicine (NAM). One of the highest honors in the fields of health and medicine, membership in NAM recognizes individuals who have ...



USC News

Yang Chai elected to National Academy of Medicine
USC News
Ostrow Associate Dean of Research Yang Chai PhD '91, DDS '96 has been elected to the National Academy of Medicine (NAM), a membership which is considered one of the highest honors in the fields of health and medicine. “Your election reflects the high ...



Michigan Medicine's Department of Physical Medicine & Rehabilitation partners with Mary Free Bed Rehabilitation ...
University of Michigan Health System News (press release)
“One of our strategic objectives is to build a statewide system for research in spinal cord injury that can lead to new innovation and discoveries,” says Denise Tate, Ph.D., professor of physical medicine and rehabilitation at Michigan Medicine and co ...


Google News

home | site map | Dr. Thad Thomas
© 2006